RESISTANCE TO ANTHRAPYRAZOLES AND ANTHRACYCLINES IN MULTIDRUG-RESISTANT P388 MURINE LEUKEMIA-CELLS - REVERSAL BY CALCIUM BLOCKERS AND CALMODULIN ANTAGONISTS
- 1 September 1986
- journal article
- research article
- Vol. 46 (9) , 4352-4356
Abstract
A series of anthrapyrazoles was examined for their cytotoxic effect on P388 cells resistant (P388R) to anthracyclines, N-[4-(9-acridinylamino)-3-methoxyphenyl]methanesulfonamide, trimetrexate, and vinblastine. The degree of resistance of P388R cells to Adriamycin (ADR) and daunomycin was 50-fold and 38-fold, respectively when compared to the parent cell line (P388S). The Adriamycin-resistant cells were highly cross-resistant to some anthrapyrazoles, but the degree of cross-resistance was not uniform and was less than 3-fold for one member of the series. The lipophilicity of these compounds appeared to correlate to some extent with the level of resistance. The calcium channel blockers verapamil (VER) and diltiazem and the calmodulin antagonist trifluoperazine potentiated the cytotoxicity of the anthrapyrazoles and ADR in P388R. This potentiating effect was concentration dependent with VER being the most efficacious. VER increased ADR cytotoxicity by greater than 10-fold and CI-937 by almost 40-fold. However, VER, diltiazem, and trifluoperazine had no effect on ADR or anthrapyrazole activity in P388S cells. The antiarrhythmic drug quinidine, and the detergent, Tween 80, also potentiated ADR activity in P388R cells to the same extent as VER. Both the net accumulation and efflux of [3H]daunomycin were altered in P388R cells by nontoxic concentrations of Tween 80 in a fashion virtually identical to that demonstrated for VER. These data suggest that agents which potentiate drug cytotoxicity in P388R cells may do so by their interaction with the lipid domain of the plasma membrane. In addition, these results demonstrate that some members of the new series of DNA binding drugs, the anthrapyrazoles, may be active against anthracycline-resistant tumors and that, where cross-resistance to them occurs, it can be partially reversed by agents such as VER.This publication has 23 references indexed in Scilit:
- DAUNORUBICIN-RESISTANT CHINESE-HAMSTER OVARY CELLS EXPRESSING MULTIDRUG RESISTANCE AND A CELL-SURFACE P-GLYCOPROTEIN1983
- CIRCUMVENTION OF VINCRISTINE AND ADRIAMYCIN RESISTANCE INVITRO AND INVIVO BY CALCIUM INFLUX BLOCKERS1983
- Interaction of psychotropic drugs with phospholipidsBiochemical Pharmacology, 1982
- INCREASED ACCUMULATION OF VINCRISTINE AND ADRIAMYCIN IN DRUG-RESISTANT P388-TUMOR CELLS FOLLOWING INCUBATION WITH CALCIUM-ANTAGONISTS AND CALMODULIN INHIBITORS1982
- Potential antitumor agents. 34. Quantitative relationships between DNA binding and molecular structure for 9-anilinoacridines substituted in the anilino ringJournal of Medicinal Chemistry, 1981
- MECHANISM OF CROSS-RESISTANCE BETWEEN VINCRISTINE AND DAUNORUBICIN IN EHRLICH ASCITES TUMOR-CELLS1978
- INVIVO CHARACTERISTICS OF RESISTANCE AND CROSS-RESISTANCE OF AN ADRIAMYCIN-RESISTANT SUBLINE OF P388 LEUKEMIA1978
- Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cellsBiochemical Pharmacology, 1978
- Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemiaBiochemical Pharmacology, 1978
- DECREASED RETENTION OF ACTINOMYCIN-D AS BASIS FOR CROSS-RESISTANCE IN ANTHRACYCLINE-RESISTANT SUBLINES OF P388 LEUKEMIA1977